These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 10922411)

  • 1. High frequency of multiple melanomas and breast and pancreas carcinomas in CDKN2A mutation-positive melanoma families.
    Borg A; Sandberg T; Nilsson K; Johannsson O; Klinker M; Måsbäck A; Westerdahl J; Olsson H; Ingvar C
    J Natl Cancer Inst; 2000 Aug; 92(15):1260-6. PubMed ID: 10922411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive mutational analysis of CDKN2A and CDK4 in Greek patients with cutaneous melanoma.
    Nikolaou V; Kang X; Stratigos A; Gogas H; Latorre MC; Gabree M; Plaka M; Njauw CN; Kypreou K; Mirmigi I; Stefanaki I; Tsao H
    Br J Dermatol; 2011 Dec; 165(6):1219-22. PubMed ID: 21801156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of germline PALB2 mutations in melanoma-prone families with CDKN2A mutations and pancreatic cancer.
    Yang XR; Jessop L; Myers T; Amundadottir L; Pfeiffer RM; Wheeler W; Pike KM; Yuenger J; Burdett L; Yeager M; Chanock SJ; Tucker MA; Goldstein AM
    Fam Cancer; 2011 Sep; 10(3):545-8. PubMed ID: 21614589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple Primary Melanoma Associated with CDKN2A Mutation-Case Report and Review of the Literature.
    Nurla LA; Aşchie M; Cozaru GC; Boșoteanu M
    Medicina (Kaunas); 2024 May; 60(5):. PubMed ID: 38792946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic variants in DNA repair genes and the risk of cutaneous malignant melanoma in melanoma-prone families with/without CDKN2A mutations.
    Liang XS; Pfeiffer RM; Wheeler W; Maeder D; Burdette L; Yeager M; Chanock S; Tucker MA; Goldstein AM; Yang XR
    Int J Cancer; 2012 May; 130(9):2062-6. PubMed ID: 21671477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A flexible multiplex bead-based assay for detecting germline CDKN2A and CDK4 variants in melanoma-prone kindreds.
    Lang JM; Shennan M; Njauw JC; Luo S; Bishop JN; Harland M; Hayward NK; Tucker MA; Goldstein AM; Landi MT; Puig S; Gruis NA; Bergman W; Bianchi-Scarra G; Ghiorzo P; Hogg D; Tsao H
    J Invest Dermatol; 2011 Feb; 131(2):480-6. PubMed ID: 21085193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognosis of CDKN2A germline mutation in patients with familial melanoma: a systematic review and meta-analysis.
    Taibo A; Paradela S; Suanzes-Hernández J; Balboa-Barreiro V; Amado-Bouza J; Fonseca E
    Melanoma Res; 2024 Feb; 34(1):9-15. PubMed ID: 37924530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rare missense variants in POT1 predispose to familial cutaneous malignant melanoma.
    Shi J; Yang XR; Ballew B; Rotunno M; Calista D; Fargnoli MC; Ghiorzo P; Bressac-de Paillerets B; Nagore E; Avril MF; Caporaso NE; McMaster ML; Cullen M; Wang Z; Zhang X; ; ; ; Bruno W; Pastorino L; Queirolo P; Banuls-Roca J; Garcia-Casado Z; Vaysse A; Mohamdi H; Riazalhosseini Y; Foglio M; Jouenne F; Hua X; Hyland PL; Yin J; Vallabhaneni H; Chai W; Minghetti P; Pellegrini C; Ravichandran S; Eggermont A; Lathrop M; Peris K; Scarra GB; Landi G; Savage SA; Sampson JN; He J; Yeager M; Goldin LR; Demenais F; Chanock SJ; Tucker MA; Goldstein AM; Liu Y; Landi MT
    Nat Genet; 2014 May; 46(5):482-6. PubMed ID: 24686846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MELPREDICT: a logistic regression model to estimate CDKN2A carrier probability.
    Niendorf KB; Goggins W; Yang G; Tsai KY; Shennan M; Bell DW; Sober AJ; Hogg D; Tsao H
    J Med Genet; 2006 Jun; 43(6):501-6. PubMed ID: 16169933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two Japanese families with familial pancreatic cancer with suspected pathogenic variants of CDKN2A: a case report.
    Kiyozumi Y; Matsubayashi H; Todaka A; Ashida R; Nishimura S; Kado N; Higashigawa S; Harada R; Ishihara E; Horiuchi Y; Honda G; Kenmotsu H; Serizawa M; Urakami K
    Hered Cancer Clin Pract; 2024 Jul; 22(1):11. PubMed ID: 38961426
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    McWilliams RR; Wieben ED; Chaffee KG; Antwi SO; Raskin L; Olopade OI; Li D; Highsmith WE; Colon-Otero G; Khanna LG; Permuth JB; Olson JE; Frucht H; Genkinger J; Zheng W; Blot WJ; Wu L; Almada LL; Fernandez-Zapico ME; Sicotte H; Pedersen KS; Petersen GM
    Cancer Epidemiol Biomarkers Prev; 2018 Nov; 27(11):1364-1370. PubMed ID: 30038052
    [No Abstract]   [Full Text] [Related]  

  • 12. P16-CD8-Ki67 Triple Algorithm for Prediction of CDKN2A Mutations in Patients with Multiple Primary and Familial Melanoma.
    Nurla LA; Gheorghe E; Aşchie M; Cozaru GC; Orășanu CI; Boşoteanu M
    Diagnostics (Basel); 2024 Apr; 14(8):. PubMed ID: 38667459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combining molecular and immunohistochemical analyses of key drivers in primary melanomas: interplay between germline and somatic variations.
    Bruno W; Martinuzzi C; Dalmasso B; Andreotti V; Pastorino L; Cabiddu F; Gualco M; Spagnolo F; Ballestrero A; Queirolo P; Grillo F; Mastracci L; Ghiorzo P
    Oncotarget; 2018 Jan; 9(5):5691-5702. PubMed ID: 29464027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Duplication of CXC chemokine genes on chromosome 4q13 in a melanoma-prone family.
    Yang XR; Brown K; Landi MT; Ghiorzo P; Badenas C; Xu M; Hayward NK; Calista D; Landi G; Bruno W; Bianchi-Scarrà G; Aguilera P; Puig S; Goldstein AM; Tucker MA
    Pigment Cell Melanoma Res; 2012 Mar; 25(2):243-7. PubMed ID: 22225770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retrospective study of germline variants in patients with hereditary melanoma study criteria in a real clinical practice setting.
    Villa-Gonzalez JM; Carrera Revilla S; Lombardero Gutiérrez L; Gardeazabal García J
    Clin Exp Dermatol; 2024 Jun; ():. PubMed ID: 38833603
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Maas EJ; DeBortoli E; Nathan V; Freeman NP; Mothershaw A; Smit DJ; Betz-Stablein B; Aoude LG; Stark MS; Sturm RA; Soyer HP; McInerney-Leo AM
    J Med Genet; 2024 May; ():. PubMed ID: 38724174
    [No Abstract]   [Full Text] [Related]  

  • 17. High-risk melanoma susceptibility genes and pancreatic cancer, neural system tumors, and uveal melanoma across GenoMEL.
    Goldstein AM; Chan M; Harland M; Gillanders EM; Hayward NK; Avril MF; Azizi E; Bianchi-Scarra G; Bishop DT; Bressac-de Paillerets B; Bruno W; Calista D; Cannon Albright LA; Demenais F; Elder DE; Ghiorzo P; Gruis NA; Hansson J; Hogg D; Holland EA; Kanetsky PA; Kefford RF; Landi MT; Lang J; Leachman SA; Mackie RM; Magnusson V; Mann GJ; Niendorf K; Newton Bishop J; Palmer JM; Puig S; Puig-Butille JA; de Snoo FA; Stark M; Tsao H; Tucker MA; Whitaker L; Yakobson E;
    Cancer Res; 2006 Oct; 66(20):9818-28. PubMed ID: 17047042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Features associated with germline CDKN2A mutations: a GenoMEL study of melanoma-prone families from three continents.
    Goldstein AM; Chan M; Harland M; Hayward NK; Demenais F; Bishop DT; Azizi E; Bergman W; Bianchi-Scarra G; Bruno W; Calista D; Albright LA; Chaudru V; Chompret A; Cuellar F; Elder DE; Ghiorzo P; Gillanders EM; Gruis NA; Hansson J; Hogg D; Holland EA; Kanetsky PA; Kefford RF; Landi MT; Lang J; Leachman SA; MacKie RM; Magnusson V; Mann GJ; Bishop JN; Palmer JM; Puig S; Puig-Butille JA; Stark M; Tsao H; Tucker MA; Whitaker L; Yakobson E; ;
    J Med Genet; 2007 Feb; 44(2):99-106. PubMed ID: 16905682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Germline mutations in CDKN2A are infrequent in female patients with melanoma and breast cancer.
    Nagore E; Montoro A; García-Casado Z; Botella-Estrada R; Insa A; Lluch A; López-Guerrero JA; Guillén C
    Melanoma Res; 2009 Aug; 19(4):211-4. PubMed ID: 19571771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BRCA1, BRCA2, TP53, and CDKN2A germline mutations in patients with breast cancer and cutaneous melanoma.
    Monnerat C; Chompret A; Kannengiesser C; Avril MF; Janin N; Spatz A; Guinebretière JM; Marian C; Barrois M; Boitier F; Lenoir GM; Bressac-de Paillerets B
    Fam Cancer; 2007; 6(4):453-61. PubMed ID: 17624602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.